AD is characterized by the loss of synapses and the pathologic accumulation of Aβ and hyperphosphorylated tau into the brain [4, 5]; as well as by reduced levels of Aβ and synaptic proteins, and enhanced concentrations of tau and phosphorylated tau in the cerebrospinal fluid (CSF) [1–3]. This evidence concerns the gene MAPT and Alzheimer disease.